(MENAFN- Investor Brand Network) Fifty 1 Labs (OTC: FITY) , a forward-thinking leader in biotechnology and health innovation, today announced a groundbreaking achievement by its recently acquired subsidiary, Genetic Networks, in space-based biotechnology. The milestone stems from over a decade of space-based functional genomics from Dr. Corey Nislow's laboratory, with the work highlighting the pivotal role of functional genomics in diverse aspects of human health and wellness. According to Dr. Nislow, the experiment findings have the potential to unlock new pathways for pharmaceutical development and human health in space exploration.

“We are thrilled to celebrate this achievement by Genetic Networks and to have Dr. Corey Nislow as a key part of our team through this acquisition,” said Gennaro D'Urso, CEO of Fifty 1 Labs.“Corey's leadership in space genomics, combined with Genetic Networks' upcoming SpaceX missions, exemplifies the forward-thinking innovation we aim to champion at Fifty 1 Labs. His presence brings tremendous value, amplifying our ability to push the boundaries of biotechnology on Earth and beyond.”

To view the full press release, visit

About Fifty 1 Labs Inc.

Fifty 1 Labs is a dynamic biotechnology company dedicated to advancing human health through innovative research and development. With a focus on cutting-edge solutions, Fifty 1 Labs integrates advanced scientific discoveries to address challenges in medicine, wellness, and beyond.

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers : (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire,“Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: /Disclaimer

BioMedWire
Austin, Texas

512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

MENAFN01042025000224011066ID1109379371